AMED: Amedisys, Inc. (AMED) enters into a definitive agreement to be acquired by UnitedHealth Group Incorporated (UNH) for $3.8 billion or $101 per share in cash, after terminating its previous agreement with Option Care Health (OPCH).
ISEE: IVERIC bio announced that the required waiting period under the HSR Act with respect to the merger with Astellas Pharma expired on June 23, 2023.
CTIC: Swedish Orphan Biovitrum AB completes the acquisition of CTI BioPharma Corp.
Only plus or premium subscribers can access this post. Subscribe today.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok